Michelle A. Peluso - 01 Jan 2022 Form 3 Insider Report for CVS HEALTH Corp (CVS)

Role
EVP and Co-President of Retail
Signature
/s/ Michelle A. Peluso
Issuer symbol
CVS
Transactions as of
01 Jan 2022
Net transactions value
$0
Form type
3
Filing time
10 Jan 2022, 16:15:23 UTC
Previous filing
08 Oct 2021
Next filing
01 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CVS Common Stock (RSU) 110,083 01 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 01 Jan 2022 Common Stock 86,386 $74.30 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Restricted Stock Unit awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 02/26/2022.
F2 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.